The Addition of Gemtuztumab Ozogamicin to Low Dose Ara C Improves Remission Rates but Not Survival Results of the UK LRF AML14 and NCRI AML16

Christine Burnett, R. Hills, A.E. Hunter, D. Milligan, W.J. Kell, K. Wheatley, J. Yin, Mary Frances McMullin, H. Dignum, Linda Bowen, Norman Russell

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)13-14
Number of pages2
JournalBlood
Volume116
Publication statusPublished - 2010

Cite this